London’s AIM All Share index managed to find some gains during Tuesday’s session although the performance was eclipsed by the main board. The Bank of England is teasing the idea of rate cuts now that inflation is falling so that’s likely lending some support too. At the close the junior market was up just over four points at 754.55.
- Synergia Energy +67%
- Futura Medical +40%
- Beeks Financial +32%
- Helium One -25%
- Bowleven -14%
Synergia Energy [LON:SYN] stood 67% higher heading into the close. There’s no news but the company this morning published a tweet saying that a much anticipated JV was still on track.
Futura Medical [LON:FUM] was 40% higher just before the end of the day. A trading update this morning notes that 2023 was a transformative year for the business and has identified a clear gap in the market, one that has significant scale on a global basis. With new regional regulatory approvals being received it’s difficult not to see the only way as being up for the maker of the erectile dysfunction therapy.
A notable mention for Beeks Financial [LON:BKS], who we flagged in our report this morning. Their stock was 32% higher at the end of the day, although a significant weight of buying was also in evidence during Monday’s trade. Management now expects FY25 performance to be significantly ahead of previous expectations.
- SmallCap Round Up: Dekel Agri-V, Helium One, H&T Group
- SmallCap Round Up: Bushveld Minerals, Cadence Minerals, Light Science Technologies
- SmallCap Round Up: Libertine, Jarvis Securities, Helium One
Helium One [LON:HE1] was looking somewhat deflated today, down 25% as profit takers moved in off the back of the phenomenal run higher seen by the stock so far this year. There was no news behind the price action, but this still leaves year to date gains at an impressive 780%.
And Bowleven [LON:BLVN] was also languishing, down some 14% heading into the close. However trading was thin and the spread a proverbial mile wide. No news, but the stock does seem to be struggling to find much favour.
